Analysis of Chinas pharmaceutical market the basic concept毕业论文翻译Word文档下载推荐.docx

Analysis of Chinas pharmaceutical market the basic concept毕业论文翻译Word文档下载推荐.docx

《Analysis of Chinas pharmaceutical market the basic concept毕业论文翻译Word文档下载推荐.docx》由会员分享，可在线阅读，更多相关《Analysis of Chinas pharmaceutical market the basic concept毕业论文翻译Word文档下载推荐.docx（8页珍藏版）》请在冰豆网上搜索。

Writepapersnetwork:

First,thebasicconceptsrelatedtothepharmaceuticalmarketanalysis（A）thedefinitionandcharacteristicsofdrugs&

lt;

&

CPCCentralCommitteeandStateCouncilonHealthReformandDevelopmentofdecision&

gt;

stressedthatthemedicineistoprotectpeople’shealth,diseasepreventionandspecialcommodity,wemuststrengthenthedrugproduction,distribution,price,applicabletovariousaspectsofmanagement.DrugAlthoughthegeneralpropertiesofacommodity,butamatterofnationaldevelopmentplansandpeople’slivesandhealth,butalsoveryspecial.medicineisusedforprevention,treatment,diagnosisofhumandiseases,withthepurposeoftheregulationofhumanphysiologicalfunction,andprovidesforindicationsorfunctions,usageandconsumptionofsubstances,includingherbs,ChineseHerbalMedicine,Chinesemedicine,chemicalsandtheirpreparations,antibiotics,biochemicaldrugs,radioactivepharmaceuticals,serum,vaccines,bloodproductsanddiagnosticdrugs,etc.Specific,thedrugspecificitymanifestedin:

First,thesocialandpublicnatureofhumanbiologicalendowmentshavebeenpromptedasmuchaspossibletoenhancehumanhealthandprolonglifeinordertoensurehumanreproduction.Drugsbecauseoftheirspecialeffectsandhighlyvaluedinmodernsociety,therighttohealthandliferightshavebecomethebasichumanrightsprotectedbylawandtherefore,drugrelatedtothereproductionofhumansocietyanddevelopmentofdrugsistheestablishmentofuniversalpublichealthcareandmedicalinsurancesystemisbased.

Second,theroleofduality.Drugscanpreventandcurediseases,rehabilitation,healthcare,however,‘isathree-drug’,therearedifferentlevelsofanydrugsideeffects,sowellmanaged,usingthemproperly,medicinescansavelives,protectionofhealth.Onthecontrary,itwilldegenerateintoaterriblepoison,harmfultohumanhealthandsafety.

Third,thequalityofunity.Drugsphysical,chemical,biologicalpharmacy,safety,efficacy,stability,uniformityandotherqualityindicatorsmustmeetstatestandardsandonlyinlinewithnationalstandardsofdrugs,inordertoensureefficacy.lowerorhigherthantherequiredqualitystandardsarelikelytoreduceorevenlosetheirefficacyorincreaseddrugtoxicityofdrugs,sideeffects,sothedrugsintothedistributionchannels,allowingonlyaqualifiedproduct,anddefinitelynotadefectiveorsubstandardproducts.

Fourth,theidentificationoftheprofessional.Prosandconsofdrugquality,authenticity,theaverageconsumerisdifficulttoidentify.Musthaveaprofessionaltechnicalpersonnelandspecializedagencies,accordingtolegalstandards,theuseofscientificmethodsandequipmentmeettherequirementsoftheordermaketheidentification.

Fifth,theapplicablelimitationsduetolackofnecessarytreatmentandpreventionofprofessionalmedicalandpharmaceuticalknowledge,itisinmostcasesonlypracticingdoctorsandpharmacistsundertheguidanceofmedicalstafforevenincustody,inordertorationaldruguse,topreventandcurediseases,toprotecthealth.Ifdrugabuseislikelytocausepoisoningorhavedrug-induceddisease.

（B）theflowpatternofChina’spharmaceuticalWithforeignmaturepharmaceuticalmarket,China’sdrugcirculationmoretransactions,morelevelsisveryobvious.Pre-reformplannedeconomysystem,thedrugsaccordingtothenationalprogramproduction,purchaseandsale,thepricecontroloftheimplementationofnationalunity,sub-levelmanagement.Afterthereforms,China’spharmaceuticalindustry,partofamarketeconomy,butthedrugpricingbytheNationalDevelopmentandReformCommissionSecretarybyMedicaredrugprices,non-Medicaredrug,prescriptionornon-prescriptiondrugsandpsychotropicdrugclass-specificpricingindifferentcountrieswereused,themaximumretailpriceoftheNationalSteeringandthemarketpriceandothermanner.manufacturersinthepharmaceuticalfactoryaftertheex-Chiefoverthedrugtothedistribution,agency,municipal,county,wholesalers,distributorsandthentothemodeldirectlytothehospitalortendersales.Drugsfromthehandsofthefactorytothefinalconsumer,usuallyinthematuremarketsabroad,2-3,6-7inourcountrytendtohavelinks.Thereareonlythewholesalepartofthegeneraltotaldistribution,municipalandcountywholesalerswholesalers,inaddition,manufacturersoftenhavetosetupanoffice,withalllevelsofwholesalersorretailpharmaciesandhospitalstodealwith,usually,alllevelsofwholesalersandmanufacturerstoworkcanbedirectlyatthehospitalandretailpharmacysales.

Second,China’spharmaceuticalmarketsituationandproblemsSincereformandopening,China’spharmaceuticalindustry,outputvalueofabout16.6percentaverageannualgrowthrate,theoverallsizeofmedicinepharmaceuticalindustryinthenationaleconomyranked36inthe18-20bit,amediumlevel.In2001,China’spharmaceuticalindustryvalue27.7billion,accountingfor2.9%ofChina’sGDP;

2002,China’spharmaceuticalindustryworth$33billion,accountingfor3.2%ofChina’sGDP,providingthepharmaceuticalindustryasawholewasagooddevelopmenttrendemergedinthesametime,China’spharmaceuticalindustrybornoutofthetraditionalplannedeconomicsystem,fromaplannedeconomytoamarketeconomyintheprocess,duetotheopacityofChina’spharmaceuticalproductionandcirculation,coupledwiththehighprofitsofthepharmaceuticalmarket,drivenbyeconomicinterests,China’spharmaceuticalmarketisstilltherearesomeproblems.

（A）repeatedactsofmakingandsellingcounterfeitandinferiordrugsSince1998,theformerStateDrugAdministration,aftertheestablishmentofillegalmanufacturingandsellingcounterfeitandinferiordrugstokeepthepressureup,adheretothe‘fiveleftoff’principle,tocarryoutaseriesofspecialanti-counterfeitingoperations.In1998to2002,theStateDrugAdministrationCouncilhasdealtwithmorethan280,000casesofsellingcounterfeitandinferiordrugs,involvingtotal$1.8billionsellingfakegoodsdestroyeddens3088,thisreflectsthedrugregulatorydepartmentshavebeencarryingoutin-depthmanufacturingandsellingcounterfeitandinferiordrugstocombatstruggle,butitalsoexposedthecriminalsproducemorecounterfeitorsubstandarddrugscontinuetoexpandthescopeandscale,thebehaviorofmanufacturingandsellingcounterfeitdrugsismorerampantdangersofcounterfeitdrugscanbecomparedbynomeansanordinaryconsumergoods,Itmakesthemostvaluableinpatientswithseriousthreatstolifeandhealthwhileitsregularmarketorderofdestructionandtheimpactofpharmaceuticalcompaniesisself-evident.

（B）andunlicensedoperationofultra-longrangeInsomeplacesoutsidethedenselypopulated,urbanandvillagesofthealley,stillactiveinmanypharmacieswithoutalicense,beyondthescopeofpharmacysalesofsomesocialphenomenonstillexists.Relevantdatashowthatfrom1998to2002fiveyears,theNationalfairswerebanned116illegaldrugs,operatingwithoutalicensemorethan40,000households.This

Foreigntrade,lease,lend,licensebehaviordespiterepeatedprohibitions.

（C）falseadvertisingoverwhelmingDrugExaggeratetheefficacyofdrugsusedbymanypharmaceuticalcompaniesandenterprisesregardedasamarketingcanoninrecentyears,frequentillegaldrugadshitthenewspapers,accordingtotheStateFoodandDrugAdministration（hereinafterreferredtoasSFDA）ofthemonitoringresultsshow:

September1,2001to15,thecountry’s31provincialcapitalcitiespublishedonthe1318Eveningdrugadvertising,thereare957violations,accountingfor72.61%;

July15,2002to30,1589drugadvertising,illegaladvertisingashighas1357,accountingfor85.40%;

2003theproportionofillegaldrugadsto84%;

inJune2004toAugust98newspapersacrossthecountrypublishedin7315tomonitordrugadvertisingtimes,andfoundthatthereisaproblemwhichhas6980times,theratelawupto95%intheOctober26,20042004,SFDAreleasedfourth&

illegaldrugadvertisementsSummary&

inthepresenceofillegaladvertisingcompanieswithmorethanfivetimesthelistof94companies‘match’,whichlackofwell-knowndomesticenterprises.

（D）non-standardpurchaseandsaleofdrugs,seriouscommercialbribery,kickbacks,popularMentionofdrugrebates,peopleoftenthinkofmedicalrepresentatives.Turnonthecomputercheckforcable,andmedical-relatednewsonbehalfofmorethananegative,andnot‘shady’is‘profiteering.’China’sfirstbatchof‘medicalrepresentative’appearedin1988,Bristol-MyersSquibbintheU.S.Thesemedicalrepresentative’sdutieswerenotdirectlyselldrugs,butmainlyanacademicpromotion.thentherearesomedoctors,pharmacists,medicalteachers,foreignpharmaceuticalcompaniesbegantojoinandbecomethefirstofprofessionalmedicalrepresentatives.Objectivelyspeaking,China’sfirstbatchofrepresentativesofboththebasicqualityofmedicalorprofessionalfoundationareverygood,butwiththeincreasinglycompetitivepharmaceuticalmarket,manydomesticpharmaceuticalcompanieshavetofollowthejointventureapproachtoattractbigpharmaceuticalrepresentatives,sothatmanydonothavetheexpertisetojointheranksofpeopleandsomecompaniesevenencouragepharmaceuticalsalesrepresentativetotakeunfairmeansunfaircompetition,allkindsofmedicalrepresentativeforatimeactiveintheChinesepharmaceuticalmarket,mixed,goodandbad.Now,pharmaceuticalcompaniesandhospitalsbrib